Letter

Hypercholesterolaemia

Reasons to be cautious about cholesterol lowering drugs

BMJ 2008; 337 doi: 10.1136/bmj.a1493 (Published 3 September 2008)
Cite this as: BMJ 2008;337:a1493

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mark Struthers, general practitioner1
  1. 1Flitwick Surgery, Flitwick, Bedfordshire MK45 1DZ
  1. mark.struthers{at}which.net

    There are reasons to be cautious about prescribing all cholesterol lowering drugs.1 The West Midlands Centre for Adverse Drug Reactions, which produces the Adverse Drug Reaction Bulletin, has recently issued a warning via the Food and Drug Administration (FDA) concerning a potentially increased …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular